C. Mr, A. R. , A. Rm, and . Green-l, Preventing medication errors in cancer chemotherapy

P. J. Beam-s, B. A. , and H. C. , Retrospective analysis of mortalities associated with medication errors

D. P. Bateman-r, . Taxis-k, and . Barber-n, Errors associated with the preparation of aseptic products in UK hospital pharmacies : lessons from the national aseptic error reporting scheme Qual Saf Health Care Ethnographic study of incidence and severity of intravenous drug errors, BMJ, vol.19326, issue.57391, pp.29-39, 2003.

L. Grognec, C. , L. A. , M. J. Da, and L. B. , Medication errors resulting from drug preparation and administration. Therapie, pp.391-400, 2005.

E. Mc, C. Mj, and O. M. Hidalgo-e, Errors evolution and analysis in antineoplastic drug preparation during one year. Pharm World Sci, pp.178-81, 1996.

U. A. , S. K. , A. S. , and D. Ds, Medication errors in chemotherapy preparation and administration: a survey conducted among oncology nurses in Turkey

G. B. , P. Jf, L. V. , and L. I. , Analysis of a manufacturing process example for cytotoxics in a hospital pharmacy, J Pharm Clin, vol.20, issue.3, pp.145-153, 2001.

L. S. , D. Jp, D. K. , and T. E. , Incidence and risk factors of preparation errors in a centralized cytotoxic preparation unit, Pharm World Sci, vol.23, issue.3, pp.102-108, 2001.

R. F. , S. G. , S. Hm, and S. V. , Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs, BMC Cancer, vol.11, p.478, 2011.

B. B. , M. N. , B. M. , and M. Ml, The application of hazard analysis and critical control points and risk management in the preparation of anti-cancer drugs

P. La, A. R. , C. R. , and G. Jr, Update on safe handling of hazardous drugs: the advice of experts

C. Jl and . Gosselin-p, Implementing a multiple-isolator unit for centralized preparation of cytotoxic drugs in a cancer center pharmacy, Pharm World Sci, vol.21, issue.4, pp.177-83, 1999.

K. Sa and S. Gj, Chemotherapy Dosing Part II: Alternative Approaches and Future Prospects, Clin Onco, vol.19, pp.99-107, 2007.

R. Française, Décision du 5 novembre 2007 relative aux bonnes pratiques de préparation. JORF n°270 du 21 novembre, Texte, p.23, 2007.

S. Plumridge-rj and . Gj, Dose-banding of cytotoxic drugs: A new concept in cancer chemotherapy

R. Française, Code de la Santé Publique Article L5121-1. En ligne

K. Ma, T. J. , L. Patterson-p, and H. Jp, Improving wait time for chemotherapy in an outpatient clinic at a comprehensive cancer center, J Oncol Prac, vol.8, issue.1, pp.1-7, 2012.

K. N. Mccann, L. , and N. J. , Evaluation of a mobile phone-based, advanced symptom management system (ASyMS®) in the management of chemotherapy-related toxicity, Support Care Cancer, vol.17, pp.437-481, 2009.

L. Mccann, M. R. , M. M. , and K. N. , Patients'perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS) to monitor and manage chemotherapy related toxicity

G. A. Toolkit, How to implement dose-banding of chemotherapy. Cancer Network Pharmacists Forum En ligne, Toolkit_Ver_3.0_FINAL.pdf. (Consulté le 23, p.5, 2010.

D. D. and D. Ef, Clinical calorimetrytenth paper a formula to estimate the approximate surface area if height and weight be knowm, Arch Intern Med, vol.17, pp.863-871, 1916.

F. Ej, G. Ea, and R. Dp, Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man, Cancer Chemother Rep, vol.50, pp.219-244, 1966.

G. Lb, B. C. , and N. D. , Is dose normalization to weight or body surface area useful in adults ?, J Natl Cancer Inst, vol.82, pp.323-325, 1990.

V. J. Baker-s and R. E. , Role of body surface area in dosing of investigational anticancer agents in adults, 1991.

K. Sa and S. Gj, Chemotherapy dosing part 1 : Scientific basis for current practice and use of body surface area, J Clin Oncol, vol.19, pp.23-27, 2007.

M. R. De, J. F. , and L. W. , Flat-fixed dosing versus Body Surface Areabased dosing of anticancer drugs in adults : does it make a difference ? The Oncol, pp.913-923, 2007.

C. E. , W. Ml, M. R. , and P. F. , Dose banding as an alternative to body surface area-based dosing of chemotherapeutic agents, Br J Cancer, vol.107, pp.1100-1106, 2012.

R. Ma, C. R. , and H. J. , Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer, Breast Cancer Res Treat, vol.139, issue.1, pp.135-143, 2013.

L. Wj, G. H. , and S. A. , Inter-and intrapatient variability in oral topotecan pharmacokinetics : implications for bodysurface area dosage regimens, Clin Cancer Res, vol.6, issue.7, pp.2685-2689, 2000.

P. Cm, B. Ve, L. Mccargar, and M. M. , Body composition as en independent determinant of 5-fluorouravil-based chemotherapy toxicity Clin Cancer Res, pp.3264-3272, 2007.

K. Sa and S. Gj, A national survey investigating UK prescribers' opinions on chemotherapy dosing and dose- banding

S. Gj, The clinical impact of dose-banding. En ligne. 9 èmes Journées du GERPAC. Octobre Presqu'île de Giens, p.3, 2006.

K. S. and S. Gj, Pharmacoeconomic aspects of dose-banding, Hospital Pharmacy Europe, vol.26, 2006.

V. J. , A. A. Trittler-r, and H. Jd, SFPO and ESOP recommendations for the practical stability of anticancer drugs: An update, Annales Pharmaceutiques Françaises, vol.71, pp.376-389, 2013.

D. Mémoire-de and . De-pharmacie-hospitalière, Université d'Angers. 107p, 2013.

T. Jf, Organisation des activités de préparation de chimiothérapies anticancéreuses, p.16

M. A. , B. C. , and T. Jf, Scheduling preparation of doses for a chemotherapy service, Annals of Operations Research, vol.78, issue.1, pp.145-154, 2010.

M. A. , B. C. , and T. Jf, Scheduling activities in a chemotherapy service, International Conference on Industrial Engineering and Systems Management (JESM'07)

F. Hl, Reducing medication errors using technological innovations, US Pharm, vol.34, issue.3, pp.15-16, 2009.

C. J. and C. Fg, Preventing medication errors in hospitals through a system approach and technological innovation : a prescription for 2010, Hosp Top, vol.84, issue.4, pp.3-8, 2006.

I. Médical:-pompe-diana, En ligne. http://fr.icumed.com/media, M1-1317F-Diana-Brochure-Rev02_low.pdf

F. J. , B. G. Verriere, and A. P. , Evaluation de la préparation par campagne de diffuseurs de 5-fluorouracil à partir d'une solution mère

G. Rigo-adrover-m, D. Gairard, and . Ac, Evaluation de l'intérêt de l'automatisation de préparations injectables de seringues pédiatriques et de poches d'analgésie. En ligne, p.7

G. M. Vazquez-r and D. A. Guerrault-moro, Qualification opérationnelle d'un automate de nutrition parentérale : Medimix® IMF. En ligne, p.7

C. Ag, G. Vazquez-r, . Mn, and . Brossard-d, Intérêt d'une pompe péristaltique pour la préparation de doses standards de cytotoxiques. En ligne, p.7

F. Cn, S. F. , and I. H. , Development and Evaluation of a Computerized Program for a One step Prescribing and Compounding of Paediatric Parenteral Nutrition

W. R. , C. A. Fields, and C. R. , Intravenous chemotherapy preparation errors: patient safety risks identified in a pan-Canadian exploratory study

Z. Mr, R. Ml, and W. A. , Neurourologic consequences of accidental intrathecal vincristine: A case report. Med Pediatr Oncol, pp.61-63, 1995.

B. Tp and J. J. , Prolonged survival following the inadvertent intrathecal administration of vincristine: clinical and electrophysiologic analyses, Clin Neuropharmacol, vol.14, issue.5, pp.457-62, 1991.

M. Me, C. Aj, E. Lo-wd, and . Mj, Inadvertent intrathecal injection of daunorubicin with fatal outcome

W. Me, W. A. Bracikowski-jp, and G. L. , Ascending myeloencephalopathy due to intrathecal vincristine sulfate. A fatal chemotherapeutic error. Cancer, pp.2041-2048, 1983.

T. Jr and N. B. , Dispensing error rate in a highly automated mail-service pharmacy practice, Pharmacotherapy, 2005.

S. Ac and C. W. , Impact of robotic antineoplastic preparation on safety, worflow and costs, J Oncol Pract, vol.8, issue.6, pp.344-349, 2012.

T. E. Van-hollebeke-m, P. B. , and J. M. , Qualité des poches de nutrition parentérale : est-elle améliorée par l'automatisation ? En ligne

R. F. , G. Ac, F. K. , and B. J. , Prévention des troubles musculo squelettiques en pharmacotechnie

T. J. , T. E. Van-hollebeke-m, and J. M. , Perception de la pénibilité au travail en unité de pharmacotechnie : Evaluation de l'impact de l'automatisation de la préparation de poches de nutrition parentérale

V. As, C. L. , F. L. , and B. L. , Evaluation des performances de l'automate PharmaHelp® pour la production de poches injectables de cytotoxiques, Communication, vol.20, pp.20-22, 2015.

T. Mj, C. G. , and G. L. , The validation of an automated self-cleaning process in a new robot for the preparation of cytotoxic drugs

J. M. , B. Ml, H. A. , and E. L. , Evaluation des performances du robot Kiro Oncology pour la préparation de poches ; seringues et diffuseurs portables d'anticancéreux. En ligne, pp.1354-1361

Y. Wa and S. J. , Implementation of an i.v.-compounding robot in a hospital-based cancer center pharmacy, Am J Health Syst Pharm, vol.74105, issue.1, pp.40-46, 2017.

A. Pacheco-ramos-m, . Pena-ae, and . Santiago, Implantacion de un robot para la elaboracion de antineoplasicos, Farm Hosp, vol.39, issue.3, pp.137-146, 2015.

W. Tk and O. C. , Media Fill to validate the aseptic preparation of cytotoxic on an automated robot. En ligne, p.3

C. S. , L. E. , L. Am, and T. G. , Centralization and technology support the hospital pharmacist in improving safety, acuracy and economy in the management of monoclonal antibodies. 18 ème congrès de l'EAHP, pp.13-1513

K. Lt, C. Jm, and D. Ms, Err is Human : Building a Safer Health System Institute of Medicine (US) Committee on Quality of Health Care in America Evaluation dispensing error detection rates in a hospital pharmacy, US, vol.37, issue.1, pp.2000-114, 1999.